Literatur zu Kapitel 8.7: Palliativmedizinische Betreuung

 Druckversion

Autor/en: U. Schuler, B. Schubert, A. Reichle
Letzte Änderung: 01.07.2008

• Back AL et al.
  Approaching difficult communication tasks in oncology.
  CA Cancer J Clin 2005;55(3):164-177.




• Burnett AK et al.
  A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.
  Cancer 2007;109(6):1114-1124.




• Christopher KA.
  The experience of donating bone marrow to a relative.
  Oncol Nurs Forum 2000;27(4):693-700.




• Couriel D et al.
  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
  Biol Blood Marrow Transplant 2006;12(4):375-396.




• Denzlinger C et al.
  Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia.
  Br J Haematol 2000;108(1):93-95.




• Funke I et al.
  Palliative cytoreduction in refractory acute leukemia: a retrospective study of 57 adult patients.
  Ann Hematol 2000;79(3):132-137.




• Gratwohl A et al.
  Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.
  Bone Marrow Transplant 2005;36(9):757-769.




• Kappauf HW.
  Kommunikation in der Onkologie.
  Hautarzt 2004;55(8):709-714.




• Kleeberg UR et al.
  Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study.
  Support Care Cancer 2005;13(5):303-310.




• Lautrette A et al.
  End-of-life family conferences: rooted in the evidence.
  Crit Care Med 2006;34(11 Suppl):364-372.




• Lautrette A et al.
  A communication strategy and brochure for relatives of patients dying in the ICU.
  N Engl J Med 2007;356(5):469-478.




• McGrath P.
  End-of-life care for hematological malignancies: the “technological imperative” and palliative care.
  J Palliat Care 2002;18(1):39-47.




• Navigante AH et al.
  Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
  J Pain Symptom Manage 2006;31(1):38-47.




• Rassin M et al.
  Caregivers' role in breaking bad news: patients, doctors, and nurses' points of view.
  Cancer Nurs 2006;29(4):302-308.




• Shirai Y et al.
  Nurses' perception of adequacy of care for leukemia patients with distress during the incurable phase and related factors.
  Leuk Res 2005;29(3):293-300.




• Shpilberg O et al.
  A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia.
  Leuk Lymphoma 1995;19(1-2):141-144.




• Stalfelt AM et al.
  The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life.
  Leuk Res 2001;25(8):673-680.




• Stalfelt AM et al.
  The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.
  Leuk Res 2003;27(6):481-488.




• Switzer GE et al.
  The effects of bereavement on adult sibling bone marrow donors' psychological well-being and reactions to donation.
  Bone Marrow Transplant 1998;21(2):181-188.

Herausgeber: Prof. Dr. H. Link
Herausgeberbeirat: Prof. Dr. P. Albers, Prof. Dr. R. Andreesen, Priv.-Doz. Dr. A. Böhme, Prof. Dr. C. Bokemeyer, Prof. Dr. U. Creutzig, Prof. Dr. G. Ehninger, Prof. Dr. M. Freund, Prof. Dr. C. Garbe, Dr. N. Gökbuget, Prof. Dr. M. Hallek, Prof. Dr. J.T. Hartmann, Prof. Dr. R. Hehlmann, Prof. emerit. Dr. H. Heimpel, Prof. Dr. A. Hochhaus, Prof. Dr. K. Höffken, Dr. G. Hübner, Prof. Dr. Th. Junginger, Priv.-Doz. Dr. U. Kaiser, Priv.-Doz. Dr. R. Kath, Prof. Dr. C.-H. Köhne, Dr. R. Mahlberg, Prof. Dr. A. Matzdorff, Prof. Dr. R.-P. Müller, Prof. Dr. J. Preiß, Prof. Dr. H.-J. Schmoll, Prof. Dr. G. von Minckwitz